Thus, ongoing CSR and AID expression in the PB of UM progressive CLL cases appears to be a hallmark of a proliferative disease in which B lymphocytes are being constitutively activated in specific tumor microenvironments.65 The gene discussed is AICDA; the disease is neoplasm.